Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1977-06-21
1978-09-26
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
2601125R, A61K 3700, C07C10352
Patent
active
041171179
ABSTRACT:
The tridecapeptide having the general formula L-leucyl-L-glutamyl-L-glutamyl-L-glutamyl-L-glutamyl-L-glutamyl-L-alanyl-L -tyrosylglycyl-L-tryptophyl-L-leucyl-L-asparagyl-L-phenylalanineamide, or a salt or protected derivative thereof. Such tridecapeptide has gastrin activity. A process of preparation of such tridecapeptide, a process of use of it, and thereapeutic or diagnostic agents incorporating it.
REFERENCES:
patent: 3931141 (1976-01-01), Wissman et al.
Chem. Abstract, 68 (1968), 8755oe.
Gregory et al., Gut 15, 683-685, (1974).
Chem. Abstract, 80 (1974), 146,514u.
Hazel Blondel
Max Planck-Gesellschaft zur Forderung der Wissenschaften
Phillips Delbert R.
LandOfFree
Tridecapetide having gastrin effect does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tridecapetide having gastrin effect, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tridecapetide having gastrin effect will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2090191